Healthcare provider profile · identity verified

Asif A Hashmi, MD FACP

Internal Medicine · AIKEN, SC · NPI 1407959976

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	812	222
Atorvastatin Calcium	Atorvastatin Calcium	672	164
Levothyroxine Sodium	Levothyroxine Sodium	629	144
Losartan Potassium	Losartan Potassium	516	138
Rosuvastatin Calcium	Rosuvastatin Calcium	490	150
Lisinopril	Lisinopril	343	89
Metformin Hcl	Metformin Hcl	301	83
Pravastatin Sodium	Pravastatin Sodium	282	69
Hydrochlorothiazide	Hydrochlorothiazide	276	77
Omeprazole	Omeprazole	223	76
Valsartan	Valsartan	221	58
Alprazolam	Alprazolam	218	48
Tamsulosin Hcl	Tamsulosin Hcl	213	67
Metoprolol Succinate	Metoprolol Succinate	212	61
Carvedilol	Carvedilol	201	53
Simvastatin	Simvastatin	189	51
Metformin Hcl Er	Metformin Hcl	177	43
Allopurinol	Allopurinol	172	48
Furosemide	Furosemide	166	51
Gabapentin	Gabapentin	159	42
Escitalopram Oxalate	Escitalopram Oxalate	140	38
Potassium Chloride	Potassium Chloride	140	35
Eliquis	Apixaban	131	32
Ozempic	Semaglutide	122	17
Glipizide Er	Glipizide	121	27
Ezetimibe	Ezetimibe	119	34
Metoprolol Tartrate	Metoprolol Tartrate	119	27
Glimepiride	Glimepiride	115	35
Hydralazine Hcl	Hydralazine Hcl	114	33
Alendronate Sodium	Alendronate Sodium	111	36
Famotidine	Famotidine	108	34
Zolpidem Tartrate	Zolpidem Tartrate	107	43
Pantoprazole Sodium	Pantoprazole Sodium	105	35
Finasteride	Finasteride	95	24
Januvia	Sitagliptin Phosphate	94	21
Jardiance	Empagliflozin	92	22
Azithromycin	Azithromycin	89	77
Trazodone Hcl	Trazodone Hcl	84	25
Tramadol Hcl	Tramadol Hcl	77	30
Atenolol	Atenolol	74	20
Irbesartan	Irbesartan	74	19
Clopidogrel	Clopidogrel Bisulfate	72	23
Fluticasone Propionate	Fluticasone Propionate	72	40
Labetalol Hcl	Labetalol Hcl	72	24
Meloxicam	Meloxicam	72	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	71	14
Sertraline Hcl	Sertraline Hcl	71	18
Fluoxetine Hcl	Fluoxetine Hcl	70	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	68	20
Bupropion Xl	Bupropion Hcl	63	17
Nifedipine Er	Nifedipine	62	17
Ondansetron Hcl	Ondansetron Hcl	61	24
Montelukast Sodium	Montelukast Sodium	60	15
Quetiapine Fumarate	Quetiapine Fumarate	60	suppressed
Donepezil Hcl	Donepezil Hcl	59	15
Levetiracetam	Levetiracetam	59	12
Synthroid	Levothyroxine Sodium	57	13
Memantine Hcl	Memantine Hcl	52	12
Paroxetine Hcl	Paroxetine Hcl	52	14
Spironolactone	Spironolactone	52	14
Mirtazapine	Mirtazapine	50	15
Clonazepam	Clonazepam	49	12
Chlorthalidone	Chlorthalidone	47	14
Farxiga	Dapagliflozin Propanediol	47	11
Oxybutynin Chloride	Oxybutynin Chloride	45	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	44	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	44	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	43	suppressed
Citalopram Hbr	Citalopram Hydrobromide	42	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	42	suppressed
Glipizide	Glipizide	41	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	41	11
Xarelto	Rivaroxaban	41	suppressed
Fenofibrate	Fenofibrate	40	suppressed
Duloxetine Hcl	Duloxetine Hcl	39	suppressed
Celecoxib	Celecoxib	38	suppressed
Lovastatin	Lovastatin	38	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	35	suppressed
Lorazepam	Lorazepam	34	17
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	32	26
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Enalapril Maleate	Enalapril Maleate	31	suppressed
Clonidine Hcl	Clonidine Hcl	30	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	29	suppressed
Mounjaro	Tirzepatide	29	suppressed
Telmisartan	Telmisartan	29	suppressed
Tizanidine Hcl	Tizanidine Hcl	29	suppressed
Mupirocin	Mupirocin	28	15
Amiodarone Hcl	Amiodarone Hcl	27	suppressed
Myrbetriq	Mirabegron	26	suppressed
Methylprednisolone	Methylprednisolone	25	22
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Prednisone	Prednisone	24	12
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Estradiol	Estradiol	22	suppressed
Midodrine Hcl	Midodrine Hcl	22	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	22	22
Bisoprolol Fumarate	Bisoprolol Fumarate	21	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	21	suppressed
Indapamide	Indapamide	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Amoxicillin	Amoxicillin	19	19
Entresto	Sacubitril/Valsartan	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Testosterone Cypionate	Testosterone Cypionate	19	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	15
Benazepril Hcl	Benazepril Hcl	17	suppressed
Edarbi	Azilsartan Medoxomil	17	suppressed
Letrozole	Letrozole	17	suppressed
Sildenafil Citrate	Sildenafil Citrate	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Nebivolol Hcl	Nebivolol Hcl	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Calcitriol	Calcitriol	15	suppressed
Acebutolol Hcl	Acebutolol Hcl	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Ranolazine Er	Ranolazine	14	suppressed
Temazepam	Temazepam	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Dilt-Xr	Diltiazem Hcl	13	suppressed
Phenytek	Phenytoin Sodium Extended	13	suppressed
Ramipril	Ramipril	13	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Digoxin	Digoxin	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Glyburide	Glyburide	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Levofloxacin	Levofloxacin	12	11
Novolin N	Insulin Nph Human Isophane	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Clindamycin Hcl	Clindamycin Hcl	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Lacosamide	Lacosamide	11	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed
Methocarbamol	Methocarbamol	11	11
Morphine Sulfate	Morphine Sulfate	11	11
Nystatin	Nystatin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error